David Debono

904 total citations · 1 hit paper
25 papers, 617 citations indexed

About

David Debono is a scholar working on Economics and Econometrics, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David Debono has authored 25 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Economics and Econometrics, 7 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David Debono's work include Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Palliative Care and End-of-Life Issues (5 papers). David Debono is often cited by papers focused on Economic and Financial Impacts of Cancer (12 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Palliative Care and End-of-Life Issues (5 papers). David Debono collaborates with scholars based in United States and Australia. David Debono's co-authors include Paul R. Helft, Jamie H. Von Roenn, Thomas J. Smith, Scott Berry, Dana S. Wollins, Lowell E. Schnipper, Jeffrey Peppercorn, Daniel M. Hayes, Michael Fisch and Lauren M. Hamel and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and JAMA Network Open.

In The Last Decade

David Debono

24 papers receiving 596 citations

Hit Papers

American Society of Clinical Oncology Statement: Toward I... 2011 2026 2016 2021 2011 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer
    2011 388 citations Paul R. Helft, David Debono et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Debono United States 9 398 251 214 138 86 25 617
Sobha Kurian United States 10 276 0.7× 341 1.4× 195 0.9× 92 0.7× 38 0.4× 20 626
Matthias Villalobos Germany 13 550 1.4× 427 1.7× 296 1.4× 159 1.2× 30 0.3× 50 899
Daan Brandenbarg Netherlands 16 173 0.4× 361 1.4× 133 0.6× 90 0.7× 61 0.7× 38 551
Lorraine Warrington United Kingdom 9 293 0.7× 569 2.3× 166 0.8× 150 1.1× 130 1.5× 16 759
Mhairi Simpson United Kingdom 10 252 0.6× 398 1.6× 148 0.7× 133 1.0× 30 0.3× 16 561
Oreofe O. Odejide United States 18 619 1.6× 474 1.9× 492 2.3× 84 0.6× 53 0.6× 64 978
Risa Liang Wong United States 12 278 0.7× 378 1.5× 104 0.5× 130 0.9× 19 0.2× 38 686
Federico Antillón United States 15 531 1.3× 211 0.8× 591 2.8× 75 0.5× 35 0.4× 26 858
Kirstin Wilkinson United Kingdom 6 143 0.4× 240 1.0× 86 0.4× 82 0.6× 55 0.6× 11 481
Denalee O’Malley United States 13 266 0.7× 385 1.5× 167 0.8× 234 1.7× 72 0.8× 40 680

Countries citing papers authored by David Debono

Since Specialization
Citations

This map shows the geographic impact of David Debono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Debono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Debono more than expected).

Fields of papers citing papers by David Debono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Debono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Debono. The network helps show where David Debono may publish in the future.

Co-authorship network of co-authors of David Debono

This figure shows the co-authorship network connecting the top 25 collaborators of David Debono. A scholar is included among the top collaborators of David Debono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Debono. David Debono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullangi, Samyukta, Benjamin Ukert, David Debono, et al.. (2024). Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members. Journal of Clinical Oncology. 43(2). 133–142. 1 indexed citations
2.
Ukert, Benjamin, et al.. (2024). Racial and Ethnic Disparities in Prior Authorizations for Patients With Cancer. The American Journal of Managed Care. 30(10). 494–499.
3.
Gordon, Aliza S., et al.. (2023). Immunotherapy in combination with chemotherapy vs. immunotherapy alone for advanced non-small cell lung cancer and programmed death ligand 1 score <50%. Cancer Treatment and Research Communications. 37. 100769–100769. 1 indexed citations
4.
Liu, Ying, Samyukta Mullangi, David Debono, et al.. (2023). Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors. JCO Oncology Practice. 19(9). 731–740. 1 indexed citations
5.
Mullangi, Samyukta, Xiaoxue Chen, Ying Liu, et al.. (2023). Association of Patient, Physician, and Practice-Level Factors with Uptake of Payer-Led Oncology Clinical Pathways. JAMA Network Open. 6(5). e2312461–e2312461. 1 indexed citations
6.
Mullangi, Samyukta, Benjamin Ukert, Gosia Sylwestrzak, et al.. (2023). Association of participation in Medicare’s Oncology Care Model with spending, utilization, and quality outcomes among commercially insured and Medicare Advantage members: A national difference-in-differences analysis.. Journal of Clinical Oncology. 41(16_suppl). 1596–1596. 1 indexed citations
7.
Kanter, Genevieve P., Ravi B. Parikh, Michael Fisch, et al.. (2022). Trends in Medically Integrated Dispensing Among Oncology Practices. JCO Oncology Practice. 18(10). e1672–e1682. 5 indexed citations
8.
Gunturu, Krishna S., et al.. (2022). Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients. Supportive Care in Cancer. 30(5). 4019–4026. 17 indexed citations
9.
Stephenson, Judith J., Rebekah Zincavage, Gregory L. Price, et al.. (2021). Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study. Patient Preference and Adherence. Volume 15. 2417–2429. 5 indexed citations
10.
Cullen, D. Kacy, et al.. (2021). Changes in prescribing of oral capecitabine versus intravenous (IV) 5-fluorouracil (5-FU) in gastrointestinal (GI) cancers during the COVID-19 pandemic.. Journal of Clinical Oncology. 39(15_suppl). e18596–e18596. 1 indexed citations
11.
Bekelman, Justin E., Atul Gupta, Ezra Fishman, et al.. (2020). Association Between a National Insurer’s Pay-for-Performance Program for Oncology and Changes in Prescribing of Evidence-Based Cancer Drugs and Spending. Journal of Clinical Oncology. 38(34). 4055–4063. 7 indexed citations
12.
13.
Ashana, Deepshikha Charan, Xiaoxue Chen, Abiy Agiro, et al.. (2019). Advance Care Planning Claims and Health Care Utilization Among Seriously Ill Patients Near the End of Life. JAMA Network Open. 2(11). e1914471–e1914471. 32 indexed citations
14.
Sylwestrzak, Gosia, John Barron, Xiaoxue Chen, et al.. (2018). Results From a Health Insurer's Clinical Pathway Program in Breast Cancer. Journal of Oncology Practice. 14(11). e711–e721. 8 indexed citations
15.
Ma, Ronald, Leonid Churilov, David Debono, et al.. (2017). Health economic implications of complications associated with pancreaticoduodenectomy at a University Hospital: a retrospective cohort cost study. HPB. 20(5). 423–431. 21 indexed citations
16.
Chou, Wen‐Ying Sylvia, Lauren M. Hamel, Chan L. Thai, et al.. (2017). Discussing prognosis and treatment goals with patients with advanced cancer: A qualitative analysis of oncologists’ language. Health Expectations. 20(5). 1073–1080. 58 indexed citations
17.
Debono, David. (2011). Palliative Care/End of Life Integration of Palliative Medicine Into Routine Oncological Care: What Does the Evidence Show Us?. 1 indexed citations
18.
Debono, David. (2011). Integration of Palliative Medicine Into Routine Oncological Care: What Does the Evidence Show Us?. Journal of Oncology Practice. 7(6). 350–354. 14 indexed citations
19.
20.
Debono, David & Patrick J. Loehrer. (1996). Thymic neoplasms. Current Opinion in Oncology. 8(2). 112–119. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sobha Kurian Breakdown of academic impact, for papers by Matthias Villalobos Breakdown of academic impact, for papers by Daan Brandenbarg Breakdown of academic impact, for papers by Lorraine Warrington Breakdown of academic impact, for papers by Mhairi Simpson Breakdown of academic impact, for papers by Oreofe O. Odejide Breakdown of academic impact, for papers by Risa Liang Wong Breakdown of academic impact, for papers by Federico Antillón Breakdown of academic impact, for papers by Kirstin Wilkinson Breakdown of academic impact, for papers by Denalee O’Malley
Rankless by CCL
2026